Natera Inc Q2 2023 Earnings Call Summary - Thomson StreetEvents

Natera Inc Q2 2023 Earnings Call Summary

Natera Inc Q2 2023 Earnings Call Summary - Thomson StreetEvents
Natera Inc Q2 2023 Earnings Call Summary
Published Aug 03, 2023
14 pages (7731 words) — Published Aug 03, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of NTRA.OQ earnings conference call or presentation 3-Aug-23 8:30pm GMT

  
Brief Excerpt:

...A. Volumes were up more than 23% versus Q2 of last year, with all products delivering strong growth. B. Revenues grew even faster, up 32% versus last year and 8% sequentially. C. We paired that revenue growth with continued COGS improvements to achieve a gross margin just above 45% compared to 39% in Q1. D. This, combined with stable operating expenses, led us to deliver another significant reduction in our quarterly cash burn....

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Natera Inc
Ticker
NTRA.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst : So first up on women's health, you mentioned that ACOG had prenatal meetings scheduled for June and September. I believe expanded carrier screening and microdeletions were on the agenda for that June meeting. So can you tell us if you have any information regarding how that meeting went? And then when -- how quickly could we see ACOG endorse 22q? Could it come right after the September meeting or just updated time line expectations there?

Question: Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst : Great. And then a follow-up here, just shifting over to oncology. Can you give us an update on your latest conversations with private payers? I understand you have Blue Cross Blue Shield of California on that pan-cancer assay, which is a positive. But how are those conversations evolving, especially ahead of some potential updates from the NCCN guidelines? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 03, 2023 / 8:30PM, NTRA.OQ - Q2 2023 Natera Inc Earnings Call And then also, I know that American Cancer Society is still trying to push in a law that commercial payers should offer the same Medicare testing. So can you just walk us through your latest expectations there? Really, what could that mean for the Signatera business?

Table Of Contents

Natera Inc Q3 2023 Earnings Call Summary – 2023-11-08 – US$ 54.00 – Edited Brief of NTRA.OQ earnings conference call or presentation 8-Nov-23 9:30pm GMT

Natera Inc at Robert W Baird Global Healthcare Conference Transcript – 2023-09-12 – US$ 54.00 – Edited Transcript of NTRA.OQ presentation 12-Sep-23 8:20pm GMT

Natera Inc at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-11 – US$ 54.00 – Edited Transcript of NTRA.OQ presentation 11-Sep-23 8:55pm GMT

Natera Inc at Canaccord Genuity Growth Conference Transcript – 2023-08-09 – US$ 54.00 – Edited Transcript of NTRA.OQ presentation 9-Aug-23 8:30pm GMT

Natera Inc Q2 2023 Earnings Call Transcript – 2023-08-03 – US$ 54.00 – Edited Transcript of NTRA.OQ earnings conference call or presentation 3-Aug-23 8:30pm GMT

Natera Inc at Goldman Sachs Healthcare Conference Summary – 2023-06-13 – US$ 54.00 – Edited Brief of NTRA.OQ presentation 13-Jun-23 9:40pm GMT

Natera Inc at Goldman Sachs Healthcare Conference Transcript – 2023-06-13 – US$ 54.00 – Edited Transcript of NTRA.OQ presentation 13-Jun-23 9:40pm GMT

Natera Inc Q1 2023 Earnings Call Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of NTRA.OQ earnings conference call or presentation 9-May-23 8:30pm GMT

Natera Inc at Cowen Health Care Conference Transcript – 2023-03-08 – US$ 54.00 – Edited Transcript of NTRA.OQ presentation 8-Mar-23 4:10pm GMT

Natera Inc at Raymond James Institutional Investors Conference Transcript – 2023-03-07 – US$ 54.00 – Edited Transcript of NTRA.OQ presentation 7-Mar-23 7:50pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Natera Inc Q2 2023 Earnings Call Summary" Aug 03, 2023. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Natera-Inc-Earnings-Call-B15672831>
  
APA:
Thomson StreetEvents. (2023). Natera Inc Q2 2023 Earnings Call Summary Aug 03, 2023. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Natera-Inc-Earnings-Call-B15672831>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.